6-KThe Wire
Lakefront Biotherapeutics NV files 6-K
Filed Jun 9, 2026 · 25d ago · Accession 0001171843-26-003984
Plain English
Lakefront Biotherapeutics announced on June 8, 2026, that it has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany, for $1.3 billion. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions.
Filing details
- Company
- Lakefront Biotherapeutics NV
- Ticker
- LKFT
- CIK
- 1421876
- Form type
- 6-K
- Filing date
- Jun 9, 2026
- Report date
- Jun 8, 2026
- Document
- f6k_060826.htm
- Size
- 11 KB